Becton Dickinson (BDX) announced it has received FDA 510(k) clearance and Conformite Europeenne marking in the European Union for its Enteric Bacterial Panel and Enteric Bacterial Panel plus for the BD COR System.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- BD’s New Vascular Access Study: What Investors Need to Know
- BDX’s SiteRite 9 Study: A New Frontier in Ultrasound-Guided Vascular Access
- Becton, Dickinson’s New Study on Sepsis Diagnostic Vials: Market Implications
- BDX’s Innovative Study on BD PosiFlush™ SafeScrub: Market Insights
- Ulta Beauty names Christopher DelOrefice CFO